STRATEGY INC. Ensuring companies translate life science innovation into market success ABOUT STRATEGY INC Clients include emerging life science entities, VCs investing in life science, biotech law firms, multinational life science companies seeking business development guidance and more • Vision & Foundation • Our Services • Global Reach • Leadership • Insight • Locations • Contact VISION & FOUNDATION 20+ years of Experience in Lifesciences Medical Devices, Biotech, Orthobiologics and Pharma Founded in 2000 Areas of Expertise OUR SERVICES Financial • Business plan development delivering a roadmap for execution • 3 - 10 Yr. financial model projections by triangulated cash flows • Valuation for acquisition, merger or licensing • Investor presentations and funding strategy • Identification of expanded indications for market growth • Key Opinion Leader identification and champion management • Exit strategy identification and implementation • Platform prioritization to validate indications with the highest ROI • Clinical adoption projections for valuation and forecasting • Commercialization potential analysis Strategic Deliverables • Define a medical technology's potential for commercial success for each of its identified target markets • Identify current and emerging treatment modalities, addressable target markets and a comprehensive evaluation of a range of proven market drivers • Acquire insight from a full assessment of projected barriers to market adoption, target customer preferences and anticipated market penetration MARKET ANALYSIS & FINANCIAL MODELS Market Analysis Financial Models • 3 – 10 - year financial model projections by triangulated cash flows • Driven by penetration and adoption rate calculations specific to target market • Determine the projected adoption based on global opinion leaders direct input to drive forecasting adoption cycles • Capture insight from one - on - one interviews with 15 to 35 carefully selected clinicians each with aligned and significant domain experience and publications • Understand therapeutic trends and practice patterns, instrumentation features, purchase decisions and cost considerations that influence technology selection • Discern candid opinions from your target market and address the chasm between technology that physicians are "interested in" and what they consistently purchase CLINICAL ADOPTION PROJECTOR ANALYSIS Strategy Inc. has performed >3,000 Clinical Adoption Projector Analyses, each with 15 – 35 aligned clinicians to the specific area of interest US ASIA EUROPE ISRAEL Strategy Inc. works with entities in: GLOBAL REACH 46% of clients in the last 15 years OUS • Strategy Inc. has domain expertise in neurostimulation, oncology, minimally invasive surgery, robotic - assisted technology, cardiovascular, orthobiologics , orthopedics including spine, gastroenterology, dermatology, wound closure, women's and men's health, energy - based therapeutics and diagnostics and others. If technology is at the leading edge of innovation, changing the paradigm of care, Strategy Inc. is usually involved. NANCY PATTERSON PRESIDENT AND CEO LAUREN RODRIGUEZ VICE PRESIDENT LEADERSHIP • Founder and a Venture Analyst with >18 years of experience in senior business development leadership executive roles with emerging technology life science companies • Leading successful commercialization of emerging technology • Author and Editor for Elsevier Lifescience Series on Commercialization and Innovation • 15 years with a focus on market assessments and investment analyses in the development of economic models • Develop tools to predict treatment adherence and analyses of medical health expenditures from large medical databases • Health economics and outcome research consulting for big pharma Acquisitions for $205M, $387M and $508M 18+ years’ experience on emerging medical device market landscape due diligence 89% of clients have emerging technology, the majority with innovation changing the paradigm of care, and a significant number preclinical INSIGHT 89% of clients have emerging technology, the majority with innovation changing the paradigm of care, and a significant number preclinical 1 2 3 4 1 New York City Raleigh, North Carolina Austin, Texas 2 3 LOCATIONS CONTACT US +1 - 919 - 900 - 0718 or +1 - 512 - 755 - 4123 Austin, Texas, New York City and Raleigh, North Carolina info@strategyinc.net www.strategyinc.net STRATEGY INC www.strategyinc.net THANK YOU